CVR number 39374927
Industry 86.9090 Other human health activities

Food4vita ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  0.8% 0.8% 0.8% 0.8% 0.8%  
Bankruptcy risk  11.9% 8.7% 11.0% 8.5% 10.3%  
Credit score (0-100)  21 29 22 28 23  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales  0 0 0 0 0  
Gross profit  589 463 412 408 352  
EBITDA  137 42.2 1.5 -35.9 14.7  
EBIT  137 42.2 1.5 -35.9 14.7  
Pre-tax profit (PTP)  136.6 39.7 -3.7 -37.5 4.5  
Net earnings  105.6 28.5 -6.3 -37.5 4.5  
Pre-tax profit without non-rec. items  137 39.7 -3.7 -37.5 4.5  
 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  114 88.2 51.8 14.3 18.8  
Interest-bearing liabilities  0.0 9.3 6.3 7.7 11.1  
Balance sheet total (assets)  251 223 136 85.5 99.5  
Net Debt  -227 -188 -122 -77.8 -80.4  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  589 463 412 408 352  
Gross profit growth  0.0% -21.3% -11.1% -0.9% -13.7%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  251 223 136 86 99  
Balance sheet change%  0.0% -11.1% -39.0% -37.1% 16.3%  
Added value  137.1 42.2 1.5 -35.9 14.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 1.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  23.3% 9.1% 0.4% -8.8% 4.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  54.7% 17.8% 1.2% -31.7% 17.0%  
ROI %  120.7% 40.0% 2.8% -87.7% 60.5%  
ROE %  93.0% 28.3% -9.0% -113.4% 27.2%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  45.3% 39.6% 38.1% 16.8% 18.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -165.2% -446.3% -7,866.3% 216.9% -548.3%  
Gearing %  0.0% 10.5% 12.1% 53.6% 58.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 52.6% 75.3% 34.1% 119.5%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  2.4 1.8 1.7 1.2 1.2  
Current Ratio  2.4 1.8 1.7 1.2 1.2  
Cash and cash equivalent  226.6 197.5 127.8 85.5 91.5  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  144.6 99.4 54.5 14.3 18.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  137 42 2 -36 15  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  137 42 2 -36 15  
EBIT / employee  137 42 2 -36 15  
Net earnings / employee  106 29 -6 -38 5